Breast cancer recurrence after immediate and delayed postmastectomy breast reconstruction-A systematic review and meta-analysis.
Claudia A BargonDanny A Young-AfatMehmet IkinciAssa BraakenburgHinne A RakhorstMarc A M MureauHelena M VerkooijenAnnemiek DoeksenPublished in: Cancer (2022)
Oncologic safety of different types and timings of postmastectomy breast reconstruction (PMBR) remains controversial. Lack of stratified risk assessment in literature makes clinical and shared decision-making complex. This meta-analysis showed that delayed autologous PMBR leads to similar (loco)regional recurrence rates as immediate autologous PMBR. Data did not allow comparing weighted average proportions of distant metastases and total breast cancer recurrence after autologous PMBR, and of all outcome measures after implant-based PMBR. Based on current evidence, oncological concerns do not seem a valid reason to withhold patients from certain reconstructive timings or techniques, and patients should equally be offered all reconstructive options they technically qualify for.
Keyphrases
- breast reconstruction
- end stage renal disease
- systematic review
- risk assessment
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- cell therapy
- prognostic factors
- stem cells
- magnetic resonance
- machine learning
- magnetic resonance imaging
- randomized controlled trial
- computed tomography
- patient reported outcomes
- heavy metals
- radical prostatectomy
- mesenchymal stem cells
- case control